PTK2 and B-cell chronic lymphocytic leukemia: Collectively, these results helped in investigating for the first time the expression of both FAK and PYK2 in CLL, underscoring the need of further investigation of the TME, which supports leukaemia progression, and deeper understanding of each molecular player in the supporting niche, applying advanced in vitro models to better resemble real conditions.